Company Filing History:
Years Active: 2022-2023
Title: Inventor Spotlight: Ingrid Bratt from Solna, Sweden
Introduction
Ingrid Bratt is a notable inventor based in Solna, Sweden, with a significant impact in the field of medical imaging technology. With two patents to her name, she is dedicated to improving the visualization and analysis of anatomical joint damage, which can be crucial for patient diagnosis and treatment.
Latest Patents
One of Ingrid’s groundbreaking patents is "Determination and Visualization of Damage to an Anatomical Joint." This innovative system focuses on obtaining a three-dimensional image representation of an anatomical joint based on a medical image stack. The invention aims to determine damage to anatomical structures by analyzing this medical image stack.
The system marks the damaged areas within the obtained three-dimensional image representation and produces a 3D model from it. Furthermore, it features a graphical user interface (GUI) that allows users to visualize and manipulate the 3D model effectively. It includes functionalities such as enabling the removal of visualizations of anatomical structures, browsing through the medical image stack, and showing the position of the currently visualized medical image.
Career Highlights
Ingrid works for Episurf Ip-Management AB, a company that specializes in innovative solutions in medical technology. Her contributions in this role demonstrate her commitment to advancing medical imaging and enhancing patient care through innovative inventions.
Collaborations
Ingrid collaborates with talented coworkers, including Richard Lilliestråle and Anders Karlsson, which fosters a collaborative environment that encourages creativity and innovation in medical technology.
Conclusion
Ingrid Bratt's work is a testament to the potential of innovation in improving health outcomes. Her patents reflect a forward-thinking approach to addressing challenges in the medical field. As an inventor, she continues to pave the way for advancements that could significantly impact patient diagnosis and treatment in the future.